In Situ and in Vitro Study of Colocalization and Segregation of α-Synuclein, Ubiquitin, and Lipids in Lewy Bodies

Gai, W.P., Yuan, H.X., Li, X.Q., Power, J.T.H., Blumbergs, P.C., Jensen, P.H.·2000·Experimental Neurology

Cited by (272)

Items 201–272 of 272

  1. A Feedforward Loop Links Gaucher and Parkinson's Diseases?
    Mark Cookson · 2011 · Cell
  2. Disintegration of amyloid fibrils of alpha-synuclein by dequalinium.
    Jae-Woo Park, In-Hwan Lee, J. Hahn, Jongsun Kim, K. Chung, S. Paik · 2008 · Biochimica et Biophysica Acta
  3. Tipping point in α-synuclein-membrane interactions from stable protein-covered vesicles to amyloid aggregation
    Katarzyna Makasewicz, Göran Carlström, Olof Stenström, Katja Bernfur, Simon Fridolf, Mikael Akke, Sara Snogerup Linse, Emma Sparr · 2024 · Cell Reports Physical Science
  4. Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson mice
    Silke Nuber, Harrison W. Hsiang, Esraa F. Keewan, Tim E. Moors, Sydney J. Reitz, Anupama Tiwari, Gary P. H. Ho, Elena Su, Wolf N. Hahn, Marie-Alexandre Adom et al. · 2025 · JCI Insight
  5. To What Extent is Anfinsen’s Thermodynamic Hypothesis Consistent With the Formation and Polymorphism of Amyloid Fibrils?
    Yi Xiao Jiang, David S Eisenberg · 2025 · Journal of Molecular Biology
  6. Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI
    Xing'an Li, Yingjiu Zhang, Peng Xie, Jinhua Piao, Yihong Hu, Ming Chang, Tao Liu, Linsen Hu · 2010 · BMC Neuroscience
  7. Proteomics and lipidomics in the human brain
    Isidró Ferrer · 2018 · Handbook of clinical neurology
  8. Dementia with Lewy bodies
    Amos D. Korczyn, Heinz Reichmann · 2006 · Journal of the Neurological Sciences
  9. RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy
    Arati Tripathi, Heba Alnakhala, Lisa Brontesi, Dennis J. Selkoe, Ulf Dettmer · 2024 · Cellular and Molecular Life Sciences
  10. Advances in our Understanding of Neurodegeneration
    K. A. Jellinger · 2007 · Elsevier eBooks
  11. Do mitochondrial DNA mutations have a role in neurodegenerative disease?
    Kim J. Krishnan, Amy Katherine Reeve, Douglass M. Turnbull · 2007 · Biochemical Society Transactions
  12. Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis
    Nathan P. Coles, Suzan Elsheikh, Agathe Quesnel, Lucy Butler, Ojodomo J. Achadu, Meez Islam, Karunakaran Kalesh, Annalisa Occhipinti, Claudio Angione, Jon Marles‐Wright et al. · 2025 · Brain Communications
  13. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
  14. Glucocerebrosidase and parkinsonism: lessons to learn
    Ivanka Marković, Nikola D. Kresojević, Vladimir Kostić · 2016 · Journal of Neurology
  15. α-Synuclein Interaction with Lipid Bilayer Discs
    Marija Dubackic, Yun Liu, Elizabeth G. Kelley, Crispin J. D. Hetherington, Michael Haertlein, Juliette M. Devos, Sara Snogerup Linse, Emma Sparr, Ulf Olsson · 2022 · Langmuir
  16. Chaperone proteins identified from synthetic proteasome inhibitor-induced inclusions in PC12 cells by proteomic analysis
    Xing'an Li, Yingjiu Zhang, Yihong Hu, Ming Chang, Tao Liu, Danping Wang, Yu Zhang, Lei Zhang, Linsen Hu · 2008 · Acta Biochimica et Biophysica Sinica
  17. Ultrastructural diversity and subcellular organization of nigral Lewy pathology in Parkinson’s disease
    Amanda J. Lewis, Lukas van den Heuvel, Marta Di Fabrizio, Kaliya Bandelier, Daria Proniakova, Domenic Burger, Notash Shafiei, Kazadi Ekundayo, Selene Offringa, Evelien Huisman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules
    Antonino Natalello, Stefania Brocca, Erika Ponzini, Carlo Santambrogio, Rita Grandori · 2023 · Frontiers in Bioscience-Landmark
  19. Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms
    Anna‐Lisa Fischer, Matthias Schmitz, Tobias Thom, Saima Zafar, Neelam Younas, Susana Correia, Angela da Silva Correia, Sezgi Canaslan, Inga Zerr · 2025 · Journal of Neurochemistry
  20. A reassessment of the Lewy body.
    Wing Lok Au, Donald B. Calne · 2005 · PubMed
  21. Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration
    K. A. Jellinger · 2003 · Humana Press eBooks
  22. Dysregulation of a Heme Oxygenase–Synuclein Axis in Parkinson Disease
    Marisa Cressatti, Hyman M. Schipper · 2022 · NeuroSci
  23. Etiology and Progression of Parkinson's Disease: Cross-Talk Between Environmental Factors and Genetic Vulnerability
    Pierre‐Olivier Fernagut · 2016 · Handbook of behavioral neuroscience
  24. Analysis of Single, Purified Inclusions as a Novel Approach to Understand Methamphetamine Neurotoxicity
    Paola Lenzi, Federica Fulceri, Gloria Lazzeri, Alessandro Casini, Stefano A. Ruggieri, Antonio Paparelli, Francesco Fornai · 2008 · Annals of the New York Academy of Sciences
  25. Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease
    Jiahao Dong, Zihan Gao, Mingrui Liu, Binglu Qian, Cheng Yuan, Hui Liu, Ni Rao, Yingjiao Liu · 2025 · Neurochemical Research
  26. Mapping the Role of Monomer Conformation in the Amyloid Formation of α-Synuclein Splice Variants
    Katherine M. Dewison, Alexander I. P. Taylor, David J. Brockwell, Sheena E. Radford · 2025 · Journal of the American Chemical Society
  27. Interplay between lipid droplets and alpha-synuclein: implication in Parkinson’s disease pathogenesis
    Walid Idi, Razan Sheta, Abid Oueslati · 2025 · Frontiers in Molecular Neuroscience
  28. Role of Calmodulin in Neurodegeneration and Neuroprotection
    Natalya A. Kurochkina, Parvathi Rudrabhatla · 2025 · Mini-Reviews in Medicinal Chemistry
  29. Modeling Parkinson’s pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity
    Anne‐Laure Mahul‐Mellier, Lukas van den Heuvel, Maxime Teixeira, Manel L. N. Boussouf, Gaspard Oudinot, Amelie Thonet, Davide Speri, Yllza Jasiqi, Christina H. Ulrich, Razan Sheta et al. · 2026 · Science Advances
  30. Sulfamerazine as a Potential Modulator against α-Synuclein Aggregation and Associated Toxicity
    Priyanka Singh, Nagesh Y. Kadam, Rajlaxmi Panigrahi, Arpit Mehrotra, Krishna Upadhayay, Madhumita Dey, Arpit Tyagi, Muhammad Aquib, Janni Nielsen, Giulia Kleijwegt et al. · 2025 · ACS Chemical Neuroscience
  31. Demência com corpúsculos de Lewy: uma entidade distinta com tratamento específico?
    Mariana Tatsch, Ricardo Nitríni, Mario Rodrigues Louzã · 2002 · Brazilian Journal of Psychiatry
  32. Cholesterol Dysregulation in APOE4 Astrocytes Promotes α-Synuclein Pathology in miBrains, a Human Brain Tissue Model
    Louise Alessandra Mesentier-Louro, Camille Goldman, Sebastian Gaese, Alice Buonfiglioli, Dimitrios Kyriakis, Ashley Harlock, Alain Ndayisaba, Emily R. Sartori, Abigail Uchitelev, John F. Fullard et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)
    Salinas-Rebolledo, Constanza, Blesa, Javier, Valenzuela-Nieto, Guillermo, Schwefel, David, López-González del Rey, Natalia, Méndez-Ruette, Maxs, Burkhalter, Janine, Carrazana, Elizabeth, Díaz-Tejeda, Francisca, Arias Catalán, Ignacio et al. · 2025 · eLife
  34. Lipid-packing defects are sufficient to modulate membrane insertion and the bound state of α-synuclein
    Miah J. Turke, Krishna M. Raghavan, Sofiya Maltseva, Daniel Henry Solz Kerr, Erin J. Adams, Ka Yee C. Lee · 2025 · Proceedings of the National Academy of Sciences
  35. Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids
    Manuel Flores‐León, Tiago F. Outeiro · 2025 · Movement Disorders
  36. Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy
    Manuel Flores‐León, Tiago F. Outeiro · 2025 · FEBS Journal
  37. Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease
    Inka Brockhausen, John S. Schutzbach, Jiabei Wang, Beth Fishwick, Jennifer Brockhausen · 2021 · Glycoconjugate Journal
  38. A novel mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein fibrils and recapitulates its pathological diversity
    Senthil T. Kumar, Anne‐Laure Mahul‐Mellier, Ramanath Narayana Hegde, Rani Moons, Pedro Magalhães, Alain Ibáñez de Opakua, Gwladys Rivière, Iman Rostami, Sonia Donzelli, Markus Zweckstetter et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  39. A dual hit of α-synuclein internalization and immune challenge leads to the formation and maintenance of Lewy body-like inclusions in human dopaminergic neurons
    Armin Bayati, Riham Ayoubi, Adriana Aguila, Cornelia E. Zorca, Chanshuai Han, Emily Banks, Emmanuelle Nguyen, Wen Luo, Irina Shlaifer, Esther del Cid‐Pellitero et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrains
    Louise Alessandra Mesentier-Louro, Camille Goldman, Sebastian Gaese, Alice Buonfiglioli, Dimitrios Kyriakis, Ashley Harlock, Alain Ndayisaba, Emily Ruth Sartori, Abigail Uchitelev, John F. Fullard et al. · 2026 · Cell stem cell
  41. Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice
    Veronica Mackey, Gladson Muthian, Marquitta Smith, Jennifer M. King, Clivel G. Charlton · 2012 · Life Sciences
  42. Gene Transfer into the Central and Peripheral Nervous System: Applications for the Treatment of Neurodegenerative Diseases and Peripheral Neuropathies
    Pierre‐François Pradat, Jacques J. Mallet · 2003 · Biotechnology and Genetic Engineering Reviews
  43. α-Synuclein enhances bioluminescent activity of firefly luciferase by facilitating luciferin localization
    Je-Hoon Kim, Chung Hee Moon, Seunho Jung, Seung R. Paik · 2008 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  44. Upregulation of α-synuclein expression in the rat cerebellum in experimental hepatic encephalopathy
    I. Suárez, Guillermo Bodega, Benjamı́n Fernández · 2010 · Neuropathology and Applied Neurobiology
  45. The Role of Copper Ion and the Ubiquitin System in Neurodegenerative Disorders
    Fabio Arnesano · 2010 · Wiley eBooks
  46. Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies
    Hilal Ahmed Lashuel, Anne‐Laure Mahul‐Mellier, Salvatore Novello, Ramanath Narayana Hegde, Yllza Jasiqi, Melek Firat Altay, Sonia Donzelli, Sean M. DeGuire, Ritwik Burai, Pedro Magalhães et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Using yeast as a model system for the genetic dissection of α-synuclein toxicity
    Vicente Sancenón, Sue-Ann Lee, Paul J. Muchowski · 2008 · Elsevier eBooks
  48. Correlation between α-synuclein and fatty acid composition in jejunum of rotenone-treated mice is dependent on acyl chain length
    Dominika Hajdúchová, Roman Holič, Peter Gajdoš, Milan Čertí­k, Erika Halášová, Renata Péčová, Michal Pokusa · 2022 · General Physiology and Biophysics
  49. Identification of differentially co-expressed genes with lipid metabolism in Parkinson’s disease by bioinformatics analysis
    Jinxiao Song, Xinyao Wang, Lipeng Dong, Shuo Hui, Ziyu Huang, Ling Fan, Yongtao Zhu, Jingru Zhao · 2025 · Neuroscience
  50. HMGCR genetic variability in Parkinson’s disease in a Spanish cohort: associations with lipid metabolism and early onset
    Rafael Díaz Belloso, Miguel Martín‐Bórnez, Daniel Macías‐García, Sergio García‐Díaz, Marta Bonilla‐Toribio, Dolores Buiza‐Rueda, Rocío Pineda Sánchez, Laura Muñoz‐Delgado, Elena Ojeda–Ruiz, Silvia Jesús et al. · 2025 · Journal of Neurology
  51. Ubiquitin signatures on aggregating proteins in neurodegeneration
    Subhashree Sahoo, Amrita Arpita Padhy, Kummari Shivani, Ashish Misra, Parul Mishra · 2025 · Essays in Biochemistry
  52. Correlative ultrastructural mapping of Lewy pathology reveals regional diversity in Parkinson’s and dementia with Lewy bodies
    Notash Shafiei, Daria Proniakova, Marija Simjanoska, Anniken Mathea Rafnum Sjødal, Daniel A. Stähli, Lukas van den Heuvel, Marta Di Fabrizio, Eve Aaron, Sandor Kasas, Mathis Solal Krause et al. · 2026 · Acta Neuropathologica
  53. Colocalization of Parkin with α-Synuclein in the Lewy Bodies of Parkinson Disease
    Michael G. Schlossmacher, Matthew P. Frosch, Wei Gai, Nutan Sharma, Miguel Medina, Tomoyo Ochiishi, Hideki Shimura, Nobutaka Hattori, Yoshikuni Mizuno, Bradley T. Hyman et al. · 2002 · Advances in behavioral biology
  54. Parkinson's Disease
    Gloria E. Meredith, Susan Totterdell · 2010 · Handbook of behavioral neuroscience
  55. The Aggresome: Proteasomes, Inclusion Bodies, and Protein Aggregation
    Jennifer A. Johnston · 2007 · Springer eBooks
  56. Tyrosine hydroxylase and Lewy body molecules immunoreactivity in the SNC neurons of an AS/AGU mutantrat
    Abdullah G. Al-Kushi, D. Russell, Philip Payne · 2012 · World Journal of Neuroscience
  57. Acute and chronic administration of 1-methyl-4-phenylpyridinium
    Patricia K. Sonsalla, Gail Duffy Zeevalk, Dwight C. German · 2008 · Elsevier eBooks
  58. Age Effects in Substantia Nigra of Asian Indians
    Phalguni Anand Alladi · 2013 · Wiley eBooks
  59. Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease
    Camelia Vlad · 2011 · KOPS (University of Konstanz)
  60. Reply: Lysosomal dysfunction in Parkinson’s disease
    Glenda Margaret Halliday, Karen E. Murphy · 2014 · Brain
  61. Tetrahydroisoquinoline Neurotoxins in Parkinson Disease
    Michael G. DeCuypere · 2010
  62. Regional lysosomal malfunction underlies the selectivity of alpha-synuclein neurodegeneration
    Kristen A. Malkus · 2011 · Scholarly Commons (University of Pennsylvania)
  63. Targeting α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy
    Arianna Bellucci, PierFranco Spano · 2011 · InTech eBooks
  64. A mutation in protein kinase C-gamma alters SNC neuron morphology and decreases synaptic vesicles in dopaminergic striatal terminals in the AS/AGU rat
    Abdullah G. Al-Kushi, David Russell, Anthony Philip Payne · 2013 · Journal of Biomedical Science and Engineering
  65. Accumulating Evidence Suggests that Parkinson’s Disease Is a Prion-Like Disorder
    Nolwen L. Rey, Élodie Angot, Christopher J.R. Dunning, Jennifer A. Steiner, Patrik Brundin · 2013 · Research and perspectives in Alzheimer's disease
  66. mtDNA Mutations in Brain Aging and Neurodegeneration
    Kim J. Krishnan, Amy Katherine Reeve · 2011 · Springer eBooks
  67. Yeast Cells as a Discovery Platform for Parkinson's Disease and other Protein Misfolding Diseases
    Karen L. Allendoerfer, Linhui Julie Su, Susan Lee Lindquist · 2008 · Elsevier eBooks
  68. α-synuclein fibril and synaptic vesicle interactions lead to vesicle destruction and increased uptake into neurons
    Amberley D. Stephens, Ana Fernández‐Villegas, Chyi Wei Chung, Oliver Vanderpoorten, Dorothea Pinotsi, Ioanna Mela, Edward Ward, Thomas M. McCoy, R. Cubitt, Alexander F. Routh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Cross-talk between genetic and environmental factors in Parkinson's disease
    Pierre‐Olivier Fernagut, Benjamin Dehay · 2025 · Handbook of behavioral neuroscience
  70. Correlative Ultrastructural Mapping of Lewy Pathology Reveals Regional Diversity in Parkinson’s and Dementia with Lewy bodies
    Notash Shafiei, Daria Proniakova, Marija Simjanoska, Anniken Mathea Rafnum Sjødal, Daniel A. Stähli, Lukas van den Heuvel, Marta Di Fabrizio, Eve Aaron, Sandor Kasas, Mathis Solal Krause et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Autophagy-lysosomal pathway in neurodegeneration
    Samantha R. McDonough, Aditya K. Rao, Jacqueline M. McAleer, Bergan M. Babrowicz, Manu Sharma · 2026 · Molecular Neurodegeneration Advances
  72. Simple Cellular Solutions to Complex Problems
    Susan Lee Lindquist, Karen L. Allendoerfer · 2009 · Research and perspectives in Alzheimer's disease